title: India's regulatory reforms on compensation for clinical trial injuries and deaths: urgent need for revisiting.
authors.affiliation: Ethical, Social, and Cultural (ESC) Program for Global Health, Sandra Rotman Centre, University Health Network, and Joint Centre for Bioethics and Dalla Lana School of Public Health, University of Toronto, Toronto, Ontario, CANADA; Centre for the AIDS Programme of Research in South Africa (CAPRISA), Durban, SOUTH AFRICA e-mail: singhj9@ukzn.ac.za.
authors.forename: Jerome Amir
authors.initials: JA
authors.lastname: Singh
mesh_terms: D002986:Clinical Trials as Topic / Q000009:adverse effects* / Q000941:ethics / Q000331:legislation & jurisprudence; D035881:Compensation and Redress / Q000941:ethics / Q000331:legislation & jurisprudence*; D004608:Eligibility Determination / Q000331:legislation & jurisprudence; D033161:Government Regulation; D006801:Humans; D007194:India; D033281:Nontherapeutic Human Experimentation / Q000331:legislation & jurisprudence; D035842:Research Subjects / Q000191:economics* / Q000331:legislation & jurisprudence; D012109:Research Support as Topic; D014947:Wounds and Injuries / Q000191:economics* / Q000209:etiology